Industry News

Oct 04, 2017
By Pharmaceutical Technology Editors
The Danish biotechnology company has been awarded a sole-source BARDA contract valued at more than $539 million for a freeze-dried smallpox vaccine.
Oct 04, 2017
By Pharmaceutical Technology Editors
Under Project BioShield, the agency could provide more than $170 million in funding to purchase and support late-stage development of Ebola vaccines and therapeutic drugs.
Oct 04, 2017
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
Genentech, AmerisourceBergen, and McKesson are providing pharma user requirements for a new project that will evaluate blockchain‘s potential in meeting requirements of the Drug Supply Chain Security Act, and preventing pharmaceutical counterfeiting.
Oct 04, 2017
By Pharmaceutical Technology Editors
Aptar Pharma will be a main exhibitor at CPhI Worldwide 2017 and will deliver three briefings on company drug-delivery developments.
Oct 03, 2017
By Pharmaceutical Technology Editors
The Cell and Gene Therapy Catapult, one of UK’s centers of excellence, has partnered with Japan’s Forum for Innovative Regenerative Medicine to boost their respective stances in the global cell and gene therapy landscape.
Oct 02, 2017
By Pharmaceutical Technology Editors
The agency published four guidance documents regarding ANDAs and amendments to ANDAs.
Sep 29, 2017
By Pharmaceutical Technology Editors
The US Department of Justice reports that AmerisourceBergen has pled guilty to illegally distributing misbranded oncology drugs and will pay a $260-million penalty.
Sep 28, 2017
By Pharmaceutical Technology Editors
The International Society for Pharmaceutical Engineering (ISPE) has revealed the results of its 2017–2018 International Board of Directors election.
Sep 28, 2017
By Pharmaceutical Technology Editors
The agency will require training for healthcare providers who prescribe immediate-release opioids.
Sep 28, 2017
By Pharmaceutical Technology Editors
FDA sent a warning letter to Shandong Vianor Biotech Co., Ltd. that claimed the company failed to follow proper data integrity and quality control procedures.
native1_300x100
lorem ipsum